Lower gum cancer

disease
On this page

Also known as cancer of gingiva of lower jawgingiva of lower jaw cancermalignant gingiva of lower jaw neoplasmmalignant neoplasm of gingiva of lower jawmalignant tumor of lower gummalignant tumour of lower gingiva

Summary

Lower gum cancer (MONDO:0004713) is a cancer. A subtype of gingival cancer — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namelower gum cancer
Mondo IDMONDO:0004713
DOIDDOID:9125
SNOMED CT363384006
UMLSC0432581
MedGen609602
GARD0024095
Anatomy (UBERON)UBERON:0011602
Is cancer (heuristic)yes

Also known as: cancer of gingiva of lower jaw · gingiva of lower jaw cancer · malignant gingiva of lower jaw neoplasm · malignant neoplasm of gingiva of lower jaw · malignant tumor of lower gum · malignant tumour of lower gingiva

Disease family

This is a subtype of gingival cancer. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › musculoskeletal system disordermusculoskeletal system cancergingival cancerlower gum cancer

Related subtypes (1): upper gum cancer

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.